The presence of increased plasma levels of sNLRP3, sCasp1p20 and IL-1 cytokines (IL-1β, IL-18) was demonstrated in hospitalized patients across the spectrum of COVID-19 severity. This evidence concerns the gene IL1A and COVID-19.